Complete DNA sequences of two oka strain varicella-zoster virus genomes.
Varicella-zoster virus (VZV) is a herpesvirus and is the causative agent of chicken pox (varicella) and shingles (herpes zoster). Active immunization against varicella became possible with the development of live attenuated varicella vaccine. The Oka vaccine strain was isolated in Japan from a child who had typical varicella, and it was then attenuated by serial passages in cell culture. Several manufacturers have obtained this attenuated Oka strain and, following additional passages, have developed their own vaccine strains. Notably, the vaccines Varilrix and Varivax are produced by GlaxoSmithKline Biologicals and Merck & Co., Inc., respectively. Both vaccines have been well studied in terms of safety and immunogenicity. In this study, we report the complete nucleotide sequence of the Varilrix (Oka-V(GSK)) and Varivax (Oka-V(Merck)) vaccine strain genomes. Their genomes are composed of 124,821 and 124,815 bp, respectively. Full genome annotations covering the features of Oka-derived vaccine genomes have been established for the first time. Sequence analysis indicates 36 nucleotide differences between the two vaccine strains throughout the entire genome, among which only 14 are involved in unique amino acid substitutions. These results demonstrate that, although Oka-V(GSK) and Oka-V(Merck) vaccine strains are not identical, they are very similar, which supports the clinical data showing that both vaccines are well tolerated and elicit strong immune responses against varicella.
Tillieux
Sueli L
SL
Viral Vaccines Research and Development, GlaxoSmithKline Biologicals, Rue de l'Institut, 89 (P31-005), B-1330 Rixensart, Belgium.
Halsey
Wendy S
WS
Thomas
Elizabeth S
ES
Voycik
John J
JJ
Sathe
Ganesh M
GM
Vassilev
Ventzislav
V
D019943:Amino Acid Substitution / Q000235:genetics; D001483:Base Sequence; D019433:Chickenpox Vaccine / Q000235:genetics*; D004279:DNA, Viral / Q000737:chemistry* / Q000235:genetics*; D005814:Genes, Viral; D016679:Genome, Viral; D014645:Herpesvirus 3, Human / Q000235:genetics*; D008969:Molecular Sequence Data; D011110:Polymorphism, Genetic; D017422:Sequence Analysis, DNA
D019433:Chickenpox Vaccine; D004279:DNA, Viral
JAMA. 2002 Feb 6;287(5):606-11
11829699
MMWR Recomm Rep. 2007 Jun 22;56(RR-4):1-40
17585291
Pediatrics. 1986 Oct;78(4 Pt 2):748-56
3020494
J Virol. 2001 Oct;75(19):9483-92
11533210
J Med Virol. 2006 Dec;78(12):1679-87
17063506
Adv Exp Med Biol. 1990;278:83-91
1963048
J Infect Dis. 1996 Nov;174 Suppl 3:S310-3
8896537
Virology. 1992 Sep;190(1):221-32
1326803
Pediatrics. 1995 May;95(5):791-6
7724330
N Engl J Med. 2007 Mar 15;356(11):1121-9
17360990
Pediatr Infect Dis J. 2007 Jul;26(7):632-8
17596807
Vaccine. 2002 Dec 13;21(3-4):281-9
12450703
J Virol. 1992 Dec;66(12):7581-4
1331541
Vaccine. 1997 Jan;15(1):61-4
9041667
J Infect Dis. 1992 Aug;166 Suppl 1:S63-8
1320652
Pediatr Infect Dis J. 2007 Feb;26(2):153-8
17259879
Arch Virol Suppl. 2001;(17):81-9
11339554
J Clin Microbiol. 2005 Oct;43(10):5415-6; author reply 5416-7
16208038
Paediatr Drugs. 2001;3(4):285-92
11354700
Pediatr Infect Dis J. 2006 Jan;25(1):12-8
16395096
N Engl J Med. 1984 Nov 22;311(21):1362-4
6092956
Arch Virol Suppl. 2001;(17):1-6
11339539
Lancet. 1974 Nov 30;2(7892):1288-90
4139526
J Virol. 2002 Nov;76(22):11447-59
12388706
MMWR Recomm Rep. 1996 Jul 12;45(RR-11):1-36
8668119
Pediatr Infect Dis J. 2000 Feb;19(2):169-70
10694011
J Virol. 2006 Oct;80(19):9850-60
16973589
Pediatrics. 1991 May;87(5):604-10
1850506
N Engl J Med. 2002 Dec 12;347(24):1909-15
12477940
J Paediatr Child Health. 2005 Nov;41(11):544-52
16398834
J Virol. 2004 Jul;78(13):6799-807
15194755
J Clin Virol. 2006 Jun;36(2):111-8
16616612
Virology. 2000 Sep 30;275(2):306-17
10998331
Virology. 2004 May 20;323(1):85-90
15165821
Infection. 2007 Oct;35(5):326-33
17710370
Pediatr Infect Dis J. 2006 Jun;25(6):475-6
16732142
Wkly Epidemiol Rec. 1998 Aug 7;73(32):241-8
9715106
J Virol. 1995 Aug;69(8):4693-701
7609034
J Pediatr. 1995 Oct;127(4):518-25
7562270
J Infect Dis. 2008 Mar 1;197 Suppl 2:S49-53
18419408
BioDrugs. 2008;22(6):387-402
18998756
J Clin Microbiol. 2004 Dec;42(12):5604-8
15583288
Virology. 2005 Feb 5;332(1):337-46
15661165
J Virol. 1998 Feb;72(2):965-74
9444989
J Virol. 1987 Sep;61(9):2877-84
3039175
J Virol. 1992 Jan;66(1):359-66
1309252
Virology. 2007 Feb 20;358(2):291-302
17027059
Vaccine. 2002 Jul 26;20(23-24):2942-9
12126906
Hum Vaccin. 2006 Sep-Oct;2(5):205-14
17035730
JAMA. 2005 Aug 17;294(7):797-802
16106004
Postgrad Med J. 1985;61 Suppl 4:53-6
3014478
J Virol. 1993 Aug;67(8):4474-83
8392592
J Virol. 1994 Dec;68(12):7850-8
7966575
Eur J Pediatr. 2007 Aug;166(8):857-64
17541639
J Infect Dis. 2000 Mar;181(3):1153-7
10720545
Pediatr Infect Dis J. 2004 Feb;23(2):132-7
14872179
Virology. 1991 Oct;184(2):625-35
1653492
J Virol Methods. 2004 Jul;119(1):25-30
15109817
Arch Dis Child. 2008 Oct;93(10):845-50
18456699
Rev Med Virol. 2003 Jul-Aug;13(4):207-22
12820183
Herpes. 2000 Oct;7(3):60-65
11867004
J Med Virol. 2003;70 Suppl 1:S82-9
12627494
Virology. 1997 Aug 4;234(2):186-95
9268149
J Infect Dis. 1974 Dec;130(6):669-72
4372275
J Med Virol. 2000 Aug;61(4):497-503
10897069
J Virol. 2008 Jan;82(2):795-804
17977964
J Infect Dis. 1996 Nov;174 Suppl 3:S324-9
8896540
Vaccine. 2000 Nov 22;19(7-8):916-23
11115716
J Infect Dis. 2008 Mar 1;197 Suppl 2:S45-8
18419407
Curr Opin Investig Drugs. 2002 Jul;3(7):996-9
12186278
Virology. 2007 Mar 15;359(2):447-58
17069870
Arch Virol Suppl. 2001;(17):49-56
11339550
Virology. 2001 Feb 1;280(1):1-6
11162813
J Med Virol. 2005 Jan;75(1):174-80
15543576
N Engl J Med. 1991 Nov 28;325(22):1545-50
1658650
J Gen Virol. 1986 Sep;67 ( Pt 9):1759-816
3018124
Arch Virol Suppl. 2001;(17):17-25
11339546
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):208-12
17182747
Virology. 2001 Jun 5;284(2):153-8
11384215